BioCellgraft is a company focused on providing regenerative oral health therapies, utilizing placental extracts like Human Connective Tissue Matrix (HCTM) to enhance both soft and hard tissue in the oro-facial sphere.
Our products are pioneering innovative, first of its kind in oral healthcare to offer regenerative tissue capabilities, helping patients mitigate many unmet oral health related conditions and avoid overall health issues by strengthening the oral cavity
Our mission is to improve quality of life through cell and tissue-enhancing therapies treating soft and hard tissue conditions, with a foundation of passion, integrity, and ethical practice
We offer injectable and implantable products for soft and hard tissue regeneration, including OraFyl (Injectable ECM/Flowable gel) and Oravance (Implantable Membrane).
Our products work by providing tissular and cellular enhancement through injection or insertion of acellular ECM, supporting tissue growth, differentiation, and regeneration.
Applications include treatment for gingival recessions, implant sealing, papilla loss (black triangle) I would leave black triangle perhaps in parenthesis for quicker understanding for the reader, thin biotype, and other soft and hard tissue conditions
Yes, our products have undergone rigorous testing and have received marketing and sales agreements with regulatory approvals, ensuring they meet safety standards.
Collected clinical cases and conducted studies demonstrated the effectiveness of our products in regenerating oral soft and hard tissues.
We recommend consulting with a healthcare professional trained in our therapies for personalized advice and treatment options.
For more information, please visit our website at www.biocellgraft.com or contact us directly at info@biocellgraft.com.
BioCellgraft is headquartered at 212 Park Avenue, New York, NY 10017, USA.